Vision and mission

Immunovia’s vision is to lead the development of bioinformatics-as­sisted diagnosis so that all patients are diagnosed in time for effective treatment, something which in turn results in a better quality of life and significantly higher survival rates.

Against this backdrop, Immunovia has a dual mission:

• Using the IMMray™ platform, to develop and establish more precise and reliable tools for early detection of complex conditions such as cancer and autoimmune diseases.

• Establishing IMMray™ PanCan-d, our blood test for early diagnosis of pancreatic cancer, as a global standard for earlier detection in high-risk groups.